GemPharmatech Co., Ltd. (SHA:688046)

China flag China · Delayed Price · Currency is CNY
18.39
+0.05 (0.27%)
At close: Jan 22, 2026
34.33%
Market Cap7.67B
Revenue (ttm)752.70M
Net Income (ttm)121.51M
Shares Out410.00M
EPS (ttm)0.30
PE Ratio62.35
Forward PE60.98
Dividend0.14 (0.76%)
Ex-Dividend DateNov 20, 2025
Volume2,008,547
Average Volume4,197,092
Open18.22
Previous Close18.34
Day's Range18.16 - 18.49
52-Week Range10.44 - 20.50
Beta0.57
RSI64.03
Earnings DateApr 23, 2026

About GemPharmatech

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other se... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 1,578
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688046
Full Company Profile

Financial Performance

In 2024, GemPharmatech's revenue was 686.84 million, an increase of 10.39% compared to the previous year's 622.19 million. Earnings were 109.82 million, a decrease of -30.89%.

Financial Statements